Maarten Spek submits: The upswing in resource prices continues. From a fundamental perspective this is no surprise. As the US, Japan, and Europe pursue an unremittingly loose monetary policy, credit supply to the “real” economy is more or less stagnant. Therefore a lot of capital is available for speculation. In addition, growth rates (and the anticipated returns) in the emerging economic nations outpace those in the West, whereas the former consume relatively high quantities of commodities.
Because of the going private transaction completed last November – a transaction led by the chief executive and backed by Apax Partners – and because it has outstanding issues of debt securities, Garda World Security Corp. is in an unusual position: it’s a reporting issuer. Over the last month, for example, it has filed an annual information form and announced preliminary results for the quarter ended April 30, 2013.
In my first column a month ago, I raised the possibility that China’s softer growth might not be all bad for us here in the UK, as long as it is generally confined to their own production and is reflected in a period of softer commodity prices. If that’s the case, a number of commodity-importing countries, ourselves included, will not suffer the sorts of strains on disposable incomes that we have experienced in
In October, the International Monetary Fund painted a gloomier picture for global investors, as it projected slower growth due to slumping world trade and uncertainty in the West. Despite the forecast, big gains can still be unlocked in the faster-growing emerging markets. We believe the smaller stocks are holding the key.
Bloomberg Markets magazine recently posted a list of the “most-promising emerging and frontier markets for investors.” Rankings were determined by several investment measures, including GDP growth and ease of doing business. A slideshow from Business Insider does an excellent job showcasing these engines of growth.
Michael Johnston submits:Global X, the New York-based ETF issuer behind popular products focusing on equities of commodity producers and sector-specific China ETFs, announced today the latest additions to its ETF lineup.
The Burrill Report submits: AstraZeneca (AZN) has joined the fray of big pharma companies betting on emerging market growth as a key area of future success, saying it expects to generate double-digit growth in countries such as Brazil, Russia, India, and China, ultimately generating a quarter of its growth from such markets by 2014.
Hans Wagner submits:
Emerging markets, especially China, Brazil, India, much of Asia and other parts of Latin America will lead the rest of the world in economic growth. As a multi-year trend, this is continuation of one of the best investing themes from 2009. Demand for commodities such as copper and steel will be critical for this growth.